Published in Cancer Weekly, August 23rd, 1999
K. Tarte and colleagues from INSERM, France, sought to evaluate whether tumor cells from patients with multiple myeloma activate allogeneic and autologous T cells. They reported their findings in a recent issue of the Journal of Immunology ( "Induced Expression of B7-1 on Myeloma Cells Following Retroviral Gene Transfer Results in Tumor-Specific Recognition by Cytotoxic T Cells," Journal of Immunology, July 1, 1999;163(1):514-524).
"Results showed that myeloma cells expressed few B7-2 and no B7-1 in six cell lines and primary cells from 11 patients," wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.